FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

Oct 8, 2019 – The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of medical products for patients with rare diseases. The grants were awarded to principal investigators from academia and industry across the country. The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program, funded by … (leggi tutto)